BioSpace News Archive

Lucy Therapeutics, Inc. today announced the appointment of business-side biopharma leader Julia Gaebler, Ph.D., as Chief Business Officer.

BiondVax Pharmaceuticals Ltd. congratulates the company’s co-lead scientific research collaborator Professor Dr. Dirk Görlich, director at the Max Planck Institute for Multidisciplinary Sciences (MPI), on being awarded the inaugural $1.4 million World Laureates Association (WLA) Prize in Life Sciences or Medicine for his seminal work describing protein transport within the cell.

Nanalysis Scientific Corp. announces that on Tuesday, November 29th, 2022, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Interim Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ending September 30, 2022.

Todos Medical, Ltd. announced financial results today for the third quarter of 2022, which ended on September 30, 2022.

Cyclica receives a grant from the Bill & Melinda Gates Foundation to apply its AI-enabled drug discovery platform to discover new therapeutic options for multiple low-data biological targets with the goal of expanding the range of accessible non-hormonal contraceptive choices for women in developing countries.

Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provided a business update and announced financial results for the third quarter ended September 30, 2022.

Bio-Path Holdings, Inc. announced its financial results for the third quarter ended September 30, 2022 and provided an update on recent corporate developments.

Freeline Therapeutics Holdings plc reported financial results for the third quarter of 2022 and announced its decisions to sell its CMC-focused subsidiary in Germany to Ascend Gene and Cell Therapies Ltd., streamline its organization to increase efficiency and strengthen its financial position, and prioritize the development of FLT201 in Gaucher disease and FLT190 in Fabry disease.

Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Stifel 2022 Healthcare Conference in New York, NY on Wednesday, November 16, 2022 at 9:45 a.m. E.T.

iQure Pharma Inc. (iQure), a US-based global biotech company, has confirmed through preclinical screenings that iQ-007, a novel anticonvulsant and analgesic compound, showed no binding to targets in the drug abuse potential panel.